Amgen 2012 Annual Report Download - page 99

Download and view the complete annual report

Please find page 99 of the 2012 Amgen annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 150

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150

92
EXHIBIT 24
POWER OF ATTORNEY
KNOW ALL MEN AND WOMEN BY THESE PRESENTS, that each person whose signature appears below constitutes
and appoints Jonathan M. Peacock and Thomas J.W. Dittrich, or either of them, his or her attorney-in-fact, each with the power
of substitution, for him or her in any and all capacities, to sign any amendments to this Report, and to file the same, with exhibits
thereto and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and
confirming all that each of said attorneys-in-fact, or his or her substitute or substitutes, may do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following
persons on behalf of the registrant and in the capacities and on the dates indicated:
Signature Title Date
/S/ ROBERT A. BRADWAY Chairman of the Board, President and
Chief Executive Officer, and Director
(Principal Executive Officer)
2/27/2013
Robert A. Bradway
/S/ JONATHAN M. PEACOCK Executive Vice President and
Chief Financial Officer
(Principal Financial Officer)
2/27/2013
Jonathan M. Peacock
/S/ THOMAS J.W. DITTRICH Vice President Finance and
Chief Accounting Officer
(Principal Accounting Officer)
2/27/2013
Thomas J.W. Dittrich
/S/ DAVID BALTIMORE Director 2/27/2013
David Baltimore
/S/ FRANK J. BIONDI, JR. Director 2/27/2013
Frank J. Biondi, Jr.
/S/ FRANÇOIS DE CARBONNEL Director 2/27/2013
François de Carbonnel
/S/ VANCE D. COFFMAN Director 2/27/2013
Vance D. Coffman
/S/ ROBERT A. ECKERT Director 2/27/2013
Robert A. Eckert
/S/ REBECCA M. HENDERSON Director 2/27/2013
Rebecca M. Henderson
/S/ FRANK C. HERRINGER Director 2/27/2013
Frank C. Herringer
/S/ TYLER JACKS Director 2/27/2013
Tyler Jacks
/S/ GILBERT S. OMENN Director 2/27/2013
Gilbert S. Omenn
/S/ JUDITH C. PELHAM Director 2/27/2013
Judith C. Pelham
/S/ J. PAUL REASON Director 2/27/2013
J. Paul Reason
/S/ LEONARD D. SCHAEFFER Director 2/27/2013
Leonard D. Schaeffer
/S/ RONALD D. SUGAR Director 2/27/2013
Ronald D. Sugar